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•  Thrombocytopenia in hospitalized patients is a frequent 
occurrence with various etiologies. However, severe 
thrombocytopenia with a platelet count <15,000 is 
uncommon
•  Post-transfusion purpura (PTP) is a rare but potentially 
fatal cause of thrombocytopenia. Due to the rarity of 
PTP, it is often initially misdiagnosed, causing a delay in 
treatment. 
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Post-Transfusion Purpura: A Rare Cause of Severe Thrombocytopenia
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METHODS
•  PTP occurs primarily in women who were immunized by a prior pregnancy or transfusion. 
•  In this case, the patient had received a transfusion during a prior hospitalization 7 days prior to 
the development of PTP
•  A subsequent transfusion causes an anamnestic response and thrombocytopenia due to 
alloimunization to human platelet specific antigens.   
•  It occurs approximately 5-12 days after a prior transfusion with an incidence of 1 in 50,000 – 
100,000 transfusions. 
•  The antibody implicated in most cases is anti-HPA1a. 
•  Treatment is IVIG with or without steroids and potentially plasmapheresis. 
•  As post-transfusion purpura is easily misdiagnosed, it is crucially important to screen for 
platelet specific antibodies and in severe cases start treatment with IVIg before laboratory 
confirmation has been received. 
•  A 59-year-old female with a history of Sjogren’s syndrome 
and rheumatoid arthritis presented with extensive petechia.  
•  Labwork revealed a platelet count of 10, decreased from 211 
four days prior to admission. 
•  The patient was started on argatroban for suspected HIT in 
the setting of recent heparin use.  
•  After discovery of severe thrombocytopenia, the patient was started on 
argatroban for suspected heparin induced thrombocytopenia (HIT) in 
the setting of recent heparin use.  
•  A heparin-associated platelet antibody (HAPA) was negative, ruling 
out HIT. Argatroban was discontinued and a platelet transfusion was 
initiated. 
•  She developed 3 severe transfusion reactions that resolved with 
cessation of the transfusion. 
•  Ertapenem was discontinued to rule out drug-induced 
thrombocytopenia and an IgA level was within normal limits, excluding 
an immunoglobulin A (IgA) deficiency as the cause of repeated 
transfusion reactions
•  A peripheral smear showed decreased platelets but no evidence of 
schistocytes or spherocytes. An abdominal ultrasound showed no 
splenomegaly.
•  Human platelet angigen-1a (HPA-1a) was positive and the diagnosis of 
PTP was made. 
•  The patient received intravenous immunoglobulin (IVIg) and prednisone 
with rapid improvement in platelet count.
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